文献速递外周动脉疾病

腘动脉与上肢入路治疗股浅动脉闭塞性疾病的围术期结局比较

Periprocedural Outcomes of Popliteal vs Upper Extremity Access in the Treatment of Superficial Femoral Artery Occlusive Disease.
PubMed 文献 · J Endovasc Ther · 2021-05-10

本研究基于Vascular Quality Initiative数据库(2010年12月至2019年6月)的回顾性队列数据,比较腘动脉入路(POA)与上肢入路(UEA)治疗孤立性股浅动脉(SFA)闭塞性疾病的围术期结局。共纳入349例患者(UEA 188例,POA 161例),结果显示两组技术成功率无显著差异(88.8% vs 84.5%,p=0.230),但UEA与更高的术后并发症风险相关(多因素分析OR 2.08,95%CI 0.80-5.37,p=0.016)。技术失败与钙化程度(OR 2.4,95%CI 1.18-4.89,p=0.016)和TASC D病变(OR 5.01,95%CI 2.45-10.24,p<0.001)独立相关。

要点

  • UEA与POA治疗孤立性SFA闭塞的技术成功率无差异。
  • UEA与更高的术后并发症和入路部位并发症风险相关。
  • 技术成功取决于钙化程度和TASC II分级,POA可作UEA替代选择。

核心结论

  • UEA与POA治疗孤立性SFA闭塞性疾病的技术成功率无差异,但UEA与更高的并发症率相关。
  • 技术成功依赖于钙化程度和TASC II分类,POA应被视为UEA的可行替代入路。

研究设计与样本

  • 回顾性队列研究,使用Vascular Quality Initiative数据库2010年12月至2019年6月数据。
  • 共纳入349例接受孤立性SFA经皮介入治疗的患者,UEA 188例(53.9%),POA 161例(46.1%)。
  • 主要终点为技术成功,次要终点包括围术期并发症相关因素。

主要发现

  • POA组TASC D病变比例更高(24.8% vs 10.6%,p<0.001),≥7 Fr鞘管使用更多(14.3% vs 2.7%,p<0.001)。
  • UEA组无钙化比例更高(27.1% vs 11.2%,p<0.001),4-5 Fr鞘管使用更多(46.8% vs 34.8%,p=0.023)。
  • UEA与POA技术成功率无差异(88.8% vs 84.5%,p=0.230),多因素分析亦无差异(p=0.985)。
  • 单因素分析显示技术失败与TASC D病变(45.7% vs 12.9%,p<0.001)和严重钙化(39.1% vs 17.5%,p=0.002)相关。
  • 多因素分析证实技术失败与钙化程度(OR 2.4,95%CI 1.18-4.89,p=0.016)和TASC D病变(OR 5.01,95%CI 2.45-10.24,p<0.001)相关。

关键数值与推荐

  • TASC A病变技术成功率为95.8%,TASC D病变为65.0%。
  • 技术失败多因素OR:钙化程度2.4(95%CI 1.18-4.89,p=0.016),TASC D病变5.01(95%CI 2.45-10.24,p<0.001)。
  • 术后并发症多因素OR(UEA vs POA):2.08(95%CI 0.80-5.37,p=0.016)。

临床怎么用

  • 治疗孤立性SFA闭塞时,POA与UEA技术成功率相当,但UEA并发症更高,POA可作为UEA的替代入路。
  • 术前应评估钙化程度和TASC分级以预测技术成功可能性。

局限性

  • 回顾性队列设计可能存在选择偏倚。
  • 数据来自Vascular Quality Initiative数据库,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Percutaneous lower extremity revascularization is being performed via upper extremity, pedal, or popliteal access with increasing frequency. This study aimed to compare periprocedural outcomes of popliteal (POA) and upper extremity (UEA) access for the treatment of isolated superficial femoral artery (SFA) occlusive disease. MATERIALS AND METHODS: A retrospective cohort study compared the outcomes of patients undergoing primary percutaneous intervention of SFA occlusive disease with POA or UEA using the Vascular Quality Initiative database from December 2010 to June 2019. Our primary endpoint was technical success. Secondary endpoints included factors associated with perioperative complications. RESULTS: A total of 349 patients underwent isolated SFA intervention through the popliteal, radial, or brachial artery. UEA was performed in 188 (53.9%) patients and POA in 161 (46.1%). Technical success with TASC A lesions was 95.8% and with TASC D lesions, 65.0%. POA had a higher proportion of TASC D lesions (24.8% vs 10.6%, p<0.001), and larger (≥7 Fr) sheath size (14.3% vs 2.7%, p<0.001). UEA had a higher proportion of no calcification (27.1% vs 11.2%, p<0.001), and smaller (4-5 Fr) sheath size (46.8% vs 34.8%, p=0.023). There was no difference in technical success between UEA and POA (88.8% vs 84.5%, p=0.230), which was also seen on multivariable analysis (p=0.985). Univariate analysis revealed technical failure was associated with TASC D lesions (45.7% vs 12.9%, p<0.001) and the presence of severe calcifications (39.1% vs 17.5%, p=0.002). Multivariable analysis confirmed technical failure was associated with degree of calcification (OR, 2.4; 95% CI, 1.18 to 4.89; p=0.016) and TASC D lesions (OR, 5.01; 95% CI, 2.45 to 10.24; p<0.001). Postoperative complications were associated with UEA on univariate (p=0.041) and multivariate analysis (OR, 2.08; 95% CI, 0.80 to 5.37; p=0.016). Access site complications were also associated with UEA compared to POA (4.3% vs 0.0%, p=0.027). CONCLUSIONS: There is no difference in technical success between UEA and POA when treating isolated SFA occlusive disease, and UEA is associated with a higher complication rate. Technical success is dependent on calcification and TASC II classification. Based on similar technical success rates and low complication rates, POA should be considered as a viable alternative to UEA when planning endovascular interventions.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Lin SK, Conway AM, Zhou A, et al. Periprocedural Outcomes of Popliteal vs Upper Extremity Access in the Treatment of Superficial Femoral Artery Occlusive Disease. J Endovasc Ther. 2021. PMID: 33970044. doi:10.1177/15266028211012402

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。